AcrySof®IQ Toric
important product Information
QUICK ACCESS INFORMATION
Scroll to Learn More
important product Information
references
© 2020 Alcon Inc. 5/20 US-ACT-1900005
91.9%
At the First Post-op visit
AcrySof®Toric IOLs HAD significantly lower incidents of repositioning than other IOLs.
Required a second repositioning 8x more often than AcrySof® IQ Toric IOLs
Of those clinically appropriate patients
OF ALL PATIENTS ARE CLINICALLY APPROPRIATE FOR ACRYSOF® IQ IOLs
Clinical Blur Starts at 0.5 D Cylinder,
ACRYSOF® IQ TORIC INTRAOCULAR LENSES IMPORTANT PRODUCT INFORMATION
CAUTION: Federal (USA) law restricts this device to the sale by or on the order of a physician. INDICATIONS: The AcrySof® IQ Toric posterior chamber intraocular lenses are intended for primary implantation in the capsular bag of the eye for visual correction of aphakia and pre-existing corneal astigmatism secondary to removal of a cataractous lens in adult patients with or without presbyopia, who desire improved uncorrected distance vision, reduction of residual refractive cylinder and increased spectacle independence for distance vision. WARNINGS/PRECAUTIONS: Careful preoperative evaluation and sound clinical judgment should be used by the surgeon to decide the risk/benefit ratio before implanting a lens in a patient with any of the conditions described in the Directions for Use labeling. Toric IOLs should not be implanted if the posterior capsule is ruptured, if the zonules are damaged, or if a primary posterior capsulotomy is planned. Rotation can reduce astigmatic correction; if necessary lens repositioning should occur as early as possible prior to lens encapsulation. All viscoelastics should be removed from both the anterior and posterior sides of the lens; residual viscoelastics may allow the lens to rotate. Optical theory suggests that high astigmatic patients (i.e., > 2.5 D) may experience spatial distortions. Possible toric IOL related factors may include residual cylindrical error or axis misalignments. Prior to surgery, physicians should provide prospective patients with a copy of the Patient Information Brochure available from Alcon for this product informing them of possible risks and benefits associated with the AcrySof® IQ Toric Cylinder Power IOLs. Studies have shown that color vision discrimination is not adversely affected in individuals with the AcrySof® Natural IOL and normal color vision. The effect on vision of the AcrySof® Natural IOL in subjects with hereditary color vision defects and acquired color vision defects secondary to ocular disease (e.g., glaucoma, diabetic retinopathy, chronic uveitis, and other retinal or optic nerve diseases) has not been studied. Do not resterilize; do not store over 45° C; use only sterile irrigating solutions such as BSS® or BSS PLUS® Sterile Intraocular Irrigating Solutions.
ATTENTION: Reference the Directions for Use labeling for a complete listing of indications, warnings and precautions.
IMPORTANT SAFETY INFORMATION
1. Lee BS, Chang DF. Comparison of the rotational stability of two toric intraocular lenses in 1273 consecutive eyes. Ophthalmology. 2018;0:1-7.
2. Oshika et al,. Comparison of incidence of repositioning surgery to correct misalignedment with three toric intraocular lenses. European Journal of Ophthalmology. 2019; 1-5.
3. Hill Distribution Data. Provided courtesy of Dr. Warren Hill. http://www.doctor-hill.com/iol-main/astigmatism_chart.htm. Accessed January 06, 2017.
4. AcrySof® IQ Toric IOL Directions for Use.
5. Miller A, Kris M, Griffiths A. Effect of small focal errors on vision. Opt Vis Sci. 1997;74(7):521-526.
References
1
Of AcrySof® IQ Toric IOLs were ≤5° of post-op alignment
81.8%
At the First Post-op visit
Of TECNIS* IOLs were ≤5° of post-op alignment
1
(n=647 eyes)
(n=626 eyes)
8x
more likely to
require repositioning.
TECNIS* Toric iols
TECNIS*
TORIC
52%
HAVE LOW CYLINDER ASTIGMATISM
That is often overlooked
Which can impair the everyday lives of low cylinder patients
0.5 D
is a visually significant blur
0.5 D
cylinder
=0.25 D
of spherical error
Alcon Online TORIC IOL Calculator
With the Barrett Algorithm
Click Here
†In a retrospective cohort study from a single private practice implanting AcrySof® IQ or TECNIS* Toric IOL’s in 1,273 eyes over an 18-month period. A digital marking system recorded the axis of toric IOLs at the conclusion of surgery, and patients were excluded from the study only if their surgery could not be performed using the marking system. Toric IOL rotation was recorded at slit lamp during dilated examination at least 1 hour post-op on the day of surgery up to 1 day after the next morning (first post –op visit). The study’s primary outcome measure was the percentage of eyes with toric IOL rotation greater than 5° and greater than 10°. The second main outcome was likelihood of requiring return to OR to reposition the IOL. Refractive outcomes were similar between the 2 groups first post-op visit.
In a retrospective case series, realignment data was collected. ‡9,430 Total Eyes, 89 IOLs repositioned total (0-67 days) 11 of 5155 (0.213%) AcrySof IQ Torics (Alcon) 62 of 3451 (1.797%) TECNIS Torics
* Trademarks are the property of their respective owners.
,1
2
3,4
5
5
†
†
,1
The Impact of Astigmatism
,1
8
,2
2
3
Proven Stability
Exceptional Performance
p<0.0001
(n=6000)
(n=626 eyes)
p<0.0001
p<0.0001
‡